INSM - Company ID 0001104506
The table below shows INSMED Inc's income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Revenue | $305.96M | $142.34M | $107.42M | $92.82M | $93.42M | $90.34M |
| Cost of revenue | $47.42M | $29.36M | $28.07M | $21.28M | $21.17M | $20.96M |
| Gross profit | - | - | - | - | - | - |
| R&D | $209.49M | $186.41M | $177.19M | $152.58M | $150.81M | $146.75M |
INSMED Inc reported annual revenue of $606.42M for fiscal year 2025. That is up 66.7% from $363.71M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A | $247.26M | $186.38M | $154.76M | $147.54M | $118.93M | $106.57M |
| Operating income | -$153.32M | -$366.00M | -$312.88M | -$248.14M | -$213.43M | -$288.90M |
| Income tax | $1.47M | $1.32M | $1.24M | $912.00K | $1.01M | $838.00K |
| Net income | -$163.56M | -$370.02M | -$321.69M | -$256.58M | -$220.52M | -$300.61M |
| EPS (diluted) | -$0.76 | -$1.75 | -$1.70 | -$1.42 | -$1.27 | -$1.94 |